GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Life Science Corp (XKRX:234080) » Definitions » Construction In Progress

JW Life Science (XKRX:234080) Construction In Progress : ₩1,439 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is JW Life Science Construction In Progress?

JW Life Science's quarterly construction in progress declined from Sep. 2023 (₩1,043 Mil) to Dec. 2023 (₩758 Mil) but then increased from Dec. 2023 (₩758 Mil) to Mar. 2024 (₩1,439 Mil).

JW Life Science's annual construction in progress declined from Dec. 2021 (₩16,903 Mil) to Dec. 2022 (₩441 Mil) but then increased from Dec. 2022 (₩441 Mil) to Dec. 2023 (₩758 Mil).


JW Life Science Construction In Progress Historical Data

The historical data trend for JW Life Science's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Life Science Construction In Progress Chart

JW Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,440.69 12,142.77 16,903.02 440.73 758.47

JW Life Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 530.98 1,988.68 1,042.87 758.47 1,438.62

JW Life Science Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


JW Life Science (XKRX:234080) Business Description

Traded in Other Exchanges
N/A
Address
28, Hanjin 1-gil, Songak-eup, Dangjin-si, Chungcheongnam-do, Seoul, KOR, 343-823
JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.

JW Life Science (XKRX:234080) Headlines

No Headlines